Esperion Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10k | 3.3k | 2.99 |
| 2023-09-30 | $3.2k | 3.3k | 0.98 |
| 2023-06-30 | $4.4k | 3.2k | 1.39 |
| 2022-12-31 | $33k | 5.2k | 6.23 |
| 2022-09-30 | $37k | 5.3k | 6.86 |
| 2022-06-30 | $41k | 6.5k | 6.26 |
| 2022-03-31 | $50k | 11k | 4.60 |
| 2021-12-31 | $74k | 15k | 5.03 |
| 2021-09-30 | $0 | 2.6k | 0.00 |
| 2021-06-30 | $843k | 27k | 31.25 |
| 2021-03-31 | $291k | 10k | 28.09 |
| 2020-12-31 | $1.6M | 60k | 26.01 |
| 2020-09-30 | $2.4M | 64k | 37.17 |
| 2020-06-30 | $3.9M | 75k | 51.33 |
| 2020-03-31 | $763k | 24k | 31.51 |
| 2019-12-31 | $1.4M | 23k | 59.61 |
| 2019-09-30 | $680k | 19k | 36.69 |
| 2019-06-30 | $1.4M | 31k | 46.48 |
| 2019-03-31 | $867k | 22k | 40.17 |
| 2018-12-31 | $733k | 16k | 45.98 |
| 2018-09-30 | $557k | 13k | 44.39 |
| 2018-06-30 | $18M | 450k | 39.19 |
| 2018-03-31 | $17M | 231k | 72.33 |
| 2017-12-31 | $665k | 10k | 65.84 |
| 2017-06-30 | $537k | 12k | 46.29 |
| 2017-03-31 | $410k | 12k | 35.34 |
| 2016-12-31 | $105k | 8.3k | 12.56 |
| 2016-09-30 | $59k | 4.2k | 13.84 |
| 2016-06-30 | $215k | 22k | 9.85 |
| 2016-03-31 | $92k | 5.5k | 16.79 |
| 2015-12-31 | $140k | 6.3k | 22.30 |
| 2015-09-30 | $206k | 8.8k | 23.48 |
| 2015-03-31 | $1.3M | 15k | 92.44 |
| 2014-12-31 | $82k | 2.0k | 41.67 |
| 2014-06-30 | $33k | 2.2k | 15.11 |
| 2014-03-31 | $24k | 1.5k | 15.54 |
| 2013-12-31 | $15k | 1.0k | 14.85 |
| 2013-09-30 | $26k | 1.4k | 19.06 |